Abbvie Inc (4AB)
TG
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current 4AB market cap is 341.84B. The company's latest EPS is USD 2.4233 and P/E is 86.32.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 45.8B | 56.2B | 58.05B | 54.5B | 56.34B |
| Operating Income | 11.36B | 17.92B | 18.12B | 12.76B | 9.14B |
| Net Income | 4.62B | 11.54B | 11.84B | 4.86B | 4.28B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 150.57B | 146.53B | 138.81B | 134.71B | 135.16B |
| Total Liabilities | 137.47B | 131.09B | 121.52B | 124.31B | 131.8B |
| Total Equity | 13.1B | 15.44B | 17.29B | 10.4B | 3.36B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 17.59B | 22.78B | 24.94B | 22.84B | 18.81B |
| Investing | -37.56B | -2.34B | -623M | -2.01B | -20.82B |
| Financing | -11.5B | -19.04B | -24.8B | -17.22B | -5.21B |
| Market Cap | 341.84B |
| Price to Earnings Ratio | 86.32 |
| Price to Sales Ratio | 6.55 |
| Price to Cash Ratio | 66.85 |
| Price to Book Ratio | 109.77 |
| Dividend Yield | 3.66% |
| Shares Outstanding | 1.77B |
| Average Volume (1 week) | 1.7k |
| Average Volume (1 Month) | 3.66k |
| 52 Week Change | 17.71% |
| 52 Week High | 204.50 |
| 52 Week Low | 42.40 |
| Spread (Intraday) | 0.44 (0.23%) |
| Company Name | Abbvie Inc |
| Address |
1521 concord pike suite 201 wilmington, delaware 19803 |
| Website | https://www.abbvie.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
